Does SECUKINUMAB Cause Injection site haemorrhage? 1,176 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,176 reports of Injection site haemorrhage have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.8% of all adverse event reports for SECUKINUMAB.
1,176
Reports of Injection site haemorrhage with SECUKINUMAB
0.8%
of all SECUKINUMAB reports
5
Deaths
61
Hospitalizations
How Dangerous Is Injection site haemorrhage From SECUKINUMAB?
Of the 1,176 reports, 5 (0.4%) resulted in death, 61 (5.2%) required hospitalization, and 14 (1.2%) were considered life-threatening.
Is Injection site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,176 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Injection site haemorrhage?
ADALIMUMAB (11,715)
EXENATIDE (5,527)
ETANERCEPT (4,674)
TIRZEPATIDE (4,389)
EVOLOCUMAB (3,720)
DULAGLUTIDE (3,028)
TERIPARATIDE (2,330)
GALCANEZUMAB-GNLM (1,415)
DUPILUMAB (1,401)
HUMIRA (1,304)
Which SECUKINUMAB Alternatives Have Lower Injection site haemorrhage Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG